Lipid testing for cardiovascular risk warning (including FDA- and CE-certified indicators such as LDL-P) and tumor marker detection.
Excellent stability, throughput and accuracy. A gold standard for clinical testing such as newborn metabolic disease screening, vitamins and therapeutic drug monitoring.
Nuclear Magnetic Resonance (NMR) spectroscopy: promotion of NMR medical applications in China. High-throughput NMR enables cost-effective, high-performance clinical screening, in-vitro diagnostic research and innovative analytical validation.
Mass spectrometry-based metabolomics analysis: the Waters Xevo TQD mass spectrometry platform approved by the China Food and Drug Administration (CFDA) for small-molecule metabolite analysis, used for targeted and untargeted metabolomics analysis of blood, urine, cerebrospinal fluid and other samples.
